Cemal Gundogdu Selected Research

Cemal Gundogdu Research Topics

Disease

6	Neoplasms (Cancer) 01/2018 - 12/2007
5	Reperfusion Injury 11/2014 - 01/2007
4	Adenocarcinoma 01/2018 - 04/2010
4	Ischemia 11/2014 - 01/2007
4	Sepsis (Septicemia) 10/2013 - 05/2010
3	Lung Injury 10/2013 - 11/2008
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2010
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 07/2011 - 12/2006
2	Stomach Neoplasms (Stomach Cancer) 04/2010 - 04/2010
2	Wounds and Injuries (Trauma) 12/2009 - 11/2008
2	Fat Embolism 11/2008 - 12/2006
2	Sinusitis 05/2008 - 06/2004
2	Pulmonary Edema 12/2006 - 07/2006
2	Inflammation (Inflammations) 08/2005 - 06/2004
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 05/2017
1	Hydrocephalus (Hydrocephaly) 06/2016
1	Necrosis 01/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Mood Disorders (Mood Disorder) 01/2016
1	Ganglion Cysts (Ganglion) 07/2014
1	Carotid Artery Diseases 05/2014
1	Aneurysm (Aneurysms) 05/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Fibrosis (Cirrhosis) 12/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2012
1	Osteoporosis 07/2012
1	Intracranial Vasospasm 12/2011
1	Hyperglycemia 06/2010
1	Atrophic Gastritis 04/2010
1	Gastritis 04/2010

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2018 - 08/2005
5	AntioxidantsIBA 05/2017 - 01/2007
5	salicylhydroxamic acid (SHAM)IBA 06/2016 - 06/2010
4	Methylprednisolone FDA LinkGeneric 07/2012 - 12/2004
4	ParaffinIBA 01/2010 - 04/2002
3	Malondialdehyde (Propanedial)IBA 01/2016 - 04/2012
3	Glutathione (Reduced Glutathione)IBA 01/2016 - 04/2012
3	Biological ProductsIBA 01/2014 - 04/2002
3	Saline SolutionIBA 07/2011 - 05/2008
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 04/2002
2	SteroidsIBA 01/2018 - 04/2002
2	NF-kappa B (NF-kB)IBA 01/2016 - 06/2010
2	CytokinesIBA 01/2016 - 10/2013
2	Phenobarbital (Luminal)FDA Link 05/2014 - 07/2006
2	Prednisolone (Predate)FDA LinkGeneric 07/2012 - 04/2010
2	alpha-Methyltyrosine (Metirosine)FDA Link 07/2012 - 04/2010
2	Methylnitronitrosoguanidine (MNNG)IBA 01/2012 - 04/2010
2	AntigensIBA 04/2010 - 04/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2008 - 08/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2008 - 08/2005
2	Erythromycin (Erycette)FDA LinkGeneric 08/2005 - 02/2004
1	Hormones (Hormone)IBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Steryl-Sulfatase (Steroid Sulfatase)IBA 01/2018
1	Organic Anion TransportersIBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	SodiumIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	estrone sulfate (Evex)FDA Link 01/2018
1	MelatoninIBA 01/2016
1	LigandsIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	agomelatine (S20098)IBA 01/2016
1	Superoxide DismutaseIBA 01/2016
1	EtoricoxibIBA 11/2014
1	Thiopental (Pentothal)FDA Link 11/2014
1	serotonin 7 receptorIBA 10/2013
1	Dexmedetomidine FDA Link 03/2013
1	8-hydroxyguanineIBA 03/2013
1	Yohimbine (Yocon)IBA 03/2013
1	Losartan (Cozaar)FDA LinkGeneric 12/2012
1	olmesartanIBA 12/2012
1	Valsartan (Vals)FDA Link 12/2012
1	Angiotensin II Type 1 Receptor BlockersIBA 12/2012
1	Moclobemide (Arima)IBA 04/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2012
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Oxidants (Oxidizing Agents)IBA 06/2010
1	Thioctic Acid (Lipoic Acid)IBA 05/2010
1	Epinephrine (Adrenaline)FDA LinkGeneric 04/2010
1	Pepsinogen CIBA 04/2010
1	HLA-C*05 antigenIBA 04/2010
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2010
1	Pepsinogen A (Pepsinogen)IBA 04/2010
1	HLA-DRB1*15 antigenIBA 04/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2010
1	HLA-A Antigens (HLA-A)IBA 04/2010
1	HLA-DR Antigens (HLA-DR)IBA 04/2010

Therapy/Procedure

6	Ligation 10/2013 - 06/2008
4	Punctures 10/2013 - 05/2010
3	Ovariectomy (Oophorectomy) 12/2012 - 06/2010
2	Therapeutics 01/2018 - 05/2008
2	Sympathectomy (Sympathectomies) 05/2014 - 12/2011
1	Anesthesia 11/2014
1	Surgical Instruments (Clip) 04/2012
1	Cannula 12/2009